No abstract available
Publication types
-
Case Reports
-
Evaluation Study
-
Letter
-
Comment
MeSH terms
-
Adenocarcinoma / mortality
-
Adenocarcinoma / pathology
-
Adenocarcinoma / therapy*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Cetuximab
-
Combined Modality Therapy
-
Female
-
Humans
-
Immunotherapy
-
Intestinal Neoplasms / mortality
-
Intestinal Neoplasms / pathology
-
Intestinal Neoplasms / therapy*
-
Intestine, Small / pathology
-
Irinotecan
-
Male
-
Middle Aged
-
Survival
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Irinotecan
-
Cetuximab
-
Camptothecin